- Lobbying
- Kelsey AND Carlson
Lobbying Arrangements Results for 'Kelsey Carlson'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to reimbursement for gene therapies. H.R. 7389, MVP Act of 2022 Issues related to the regulation of gene therapies; newborn screening; FDA appropriations |
Institute for Gene Therapies
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to diabetes and cardiovascular disease |
Boehringer Ingelheim Pharmaceuticals, Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to the pharmaceutical industry issues related to Medicare drug reimbursement |
Supernus Pharmaceuticals Inc
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to pharmaceutical drugs |
Collegium Pharmaceutical
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to the National Defense Authorization Act for FY 2024 issues related to health care diagnostics |
Illumina, Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details medical device manufacturing, servicing, and sterilization issues; FDA modernization |
Steris Corporation
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues Related to Defense and Human Performance |
Momentous
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Medicare reimbursement of pharmaceuticals general issues of interest to pharmaceutical companies |
scPharmaceuticals, Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to eye and wound care |
BioTissue
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to reimbursement for eye care procedures |
iOR Partners
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to FDA enforcement Issues related to medical device reimbursement |
Glaukos Corporation (FKA Avedro, Inc.)
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to Medicare payment for/access to radiation therapy services ARPA-H Issues related to Section 301 tariffs |
Accuray Incorporated
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to regulation of prescription drugs and biologics |
Gilead Sciences, Inc.
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to the development and approval of therapies for rare diseases |
Harmony Biosciences, LLC
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to FDA inspections |
Revance Therapeutics Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to Valley Fever and fungal vaccines |
Anivive Lifesciences
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details General FDA issues related to orphan drugs |
Catalyst Pharmaceuticals
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues relating to rulemaking around Single-use Package Drugs; Issues related to implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Bill; Issues related to supply chain... |
Endo Pharmaceuticals Inc.
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to Medicare ESRD benefit and chronic kidney disease management Issues related to medication affordability and access |
Ardelyx, Inc.
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to FDA and rare diseases |
Pharming Healthcare, Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details General Issues of interest to pharmaceutical companies Medicare reimbursement of pharmaceuticals |
Organon & Co.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to implementation of the Inflation Reduction Act of 2022, Issues relating to Medicare Part B and Medicare Part D drug pricing reforms. |
We Work for Health
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to combination product development |
Aurion Biotech
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to pharmaceutical drugs |
Amgen Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to pharmaceutical drugs |
SPARC
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to medical devices |
Medical Device Manufacturers Association
medical devices |
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details FDA issues Medicare reimbursement issues |
Eagle Pharmaceuticals Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to Medicare Part B and Part D Issues related to the pharmaceutical industry |
Biogen Inc.
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to technology and manufacturing issues related to tariffs |
Tek84
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to approval of combination products |
Neurotech Pharmaceuticals
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to Medicare coverage |
Lifeward (formerly known as ReWalk Robotics, Inc.)
medical device |
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details health care coverage |
Tennessee Rural Health Improvement Association (fkn Tennessee Farm Br. Assn.)
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Education regarding gene therapies/one-time treatments; policies and regulations impacting drugs for rare diseases and conditions; FDA modernization Value-based pricing arrangements; MVP Act - HR 2666 |
Spark Therapeutics, Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to apheresis access and reimbursement Issues related to supply chain constraints |
TERUMO BCT
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to Medicare policies impacting ESRD; Medicare Secondary Payer Act - HR 6860; ESRD Prospective Payment System; value-based care and alternative payment models; home dialysis |
U.S. Renal Care
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details issues related to the practice of allergy treatment coverage of allergy treatment |
The Allergy, Asthma & Sinus Center
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details education about rare disease therapies |
Enzyvant Therapeutics GmbH
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details issues related to pharmaceutical drugs |
ASTELLAS PHARMA US
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Issues related to health IT and medical records |
SSI Group
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to Mental Health Issues related to Medicare Part D |
Sumitomo Pharma Co., Ltd. (formerly Sunovion Pharmaceuticals, Inc.)
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details Policies and regulations impacting drugs for rare diseases and conditions; pharmaceutical pricing issues; 340B; Safe Step Act - HR 2630/S 652; FTC regulation of biopharma mergers and acquisitions P... |
HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.)
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to Medicare and Medicaid coverage and payment for chronic pain management devices; Issues related to spinal cord stimulation; Medicare beneficiary access to procedures performed in a... |
Nevro Corporation
|
JEFFREY J. KIMBELL AND ASSOCIATES | |||
Details issues related to senior health care issues related to senior housing |
Brookdale Senior Living Inc.
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Medicare beneficiary access to innovative medical technology; Medicare beneficiary access to procedures performed in ambulatory surgical centers - HR 972/S 312, Outpatient Surgery Quality and Acces... |
LivaNova USA, Inc.
|
JEFFREY J. KIMBELL AND ASSOCIATES |